Orient Bio Inc
KRX:002630

Watchlist Manager
Orient Bio Inc Logo
Orient Bio Inc
KRX:002630
Watchlist
Price: 605 KRW -1.63% Market Closed
Market Cap: 71.7B KRW

Orient Bio Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Orient Bio Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Orient Bio Inc
KRX:002630
EPS (Diluted)
-â‚©64
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
-2%
Samsung Biologics Co Ltd
KRX:207940
EPS (Diluted)
â‚©34.5k
CAGR 3-Years
47%
CAGR 5-Years
33%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
EPS (Diluted)
â‚©1.8k
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
EPS (Diluted)
-â‚©191
CAGR 3-Years
31%
CAGR 5-Years
29%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
EPS (Diluted)
-â‚©693
CAGR 3-Years
-48%
CAGR 5-Years
-24%
CAGR 10-Years
-1%
N
NanoEnTek Inc
KOSDAQ:039860
EPS (Diluted)
â‚©55
CAGR 3-Years
-37%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
No Stocks Found

Orient Bio Inc
Glance View

ORIENTBIO, Inc. engages in the research and development of biotechnology. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 104 full-time employees. The firm produces and supplies laboratory animals, including mice, rats, guinea pigs, hamsters, specific pathogen free (SPF) rabbits, beagles and others. The company also provides contract research organization (CRO) services, including CRO safety assessment and CRO new drug development services; medical and library equipment, such as barrier systems, and support services such as rodent surgery services, laboratory diagnostics services, transgenic services, genetic testing services and other services. In addition, along with its subsidiaries, the Company provides feeds, reagents, disinfectants, automobile components, power supply equipment, and other machines.

Intrinsic Value
352.78 KRW
Overvaluation 42%
Intrinsic Value
Price

See Also

What is Orient Bio Inc's EPS (Diluted)?
EPS (Diluted)
-64.1 KRW

Based on the financial report for Sep 30, 2025, Orient Bio Inc's EPS (Diluted) amounts to -64.1 KRW.

What is Orient Bio Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-2%

Back to Top